Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Liabilities and Shareholders Equity (2018 - 2025)

Zai Lab (ZLAB) has disclosed Liabilities and Shareholders Equity for 8 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 1.13% to $1.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.7 billion through Dec 2025, up 12.58% year-over-year, with the annual reading at $1.2 billion for FY2025, 1.13% down from the prior year.
  • Liabilities and Shareholders Equity hit $1.2 billion in Q4 2025 for Zai Lab, up from $1.2 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.9 billion in Q2 2021 to a low of $985.3 million in Q3 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2023.
  • Biggest YoY gain for Liabilities and Shareholders Equity was 32.67% in 2022; the steepest drop was 25.14% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $1.6 billion in 2021, then dropped by 24.21% to $1.2 billion in 2022, then dropped by 15.07% to $1.0 billion in 2023, then increased by 14.42% to $1.2 billion in 2024, then decreased by 1.13% to $1.2 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for ZLAB at $1.2 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.